C12N 15/68
Stabilisation of the vector
C12N15/68 (Stabilisation of the vector) appears on 112 US grants and 114 published applications in this corpus.
Search patents in C12N- Granted patents
- 112
- Published applications
- 114
- Assignees
- 98
- Inventors
- 302
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 6 | 0 |
| 1990 | 5 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 5 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 4 | 0 |
| 1998 | 6 | 0 |
| 1999 | 8 | 0 |
| 2000 | 4 | 0 |
| 2001 | 2 | 0 |
| 2002 | 1 | 1 |
| 2003 | 2 | 4 |
| 2004 | 1 | 4 |
| 2005 | 1 | 2 |
| 2006 | 1 | 1 |
| 2007 | 1 | 1 |
| 2008 | 0 | 3 |
| 2009 | 2 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 3 |
| 2013 | 0 | 4 |
| 2014 | 2 | 2 |
| 2015 | 1 | 5 |
| 2016 | 2 | 6 |
| 2017 | 3 | 8 |
| 2018 | 2 | 7 |
| 2019 | 1 | 9 |
| 2020 | 13 | 12 |
| 2021 | 8 | 8 |
| 2022 | 4 | 10 |
| 2023 | 3 | 8 |
| 2024 | 2 | 3 |
| 2025 | 4 | 3 |
| 2026 | 2 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Engineered DNA molecule for coding RNA22 Sep 2026US 12,742,172 B2Rinuagene Biotechnology Co., Ltd.
- Univariant extrinsic initiator control system for microbes and an in vitro assembly of large recombinant DNA molecules from multiple components2 Jun 2026US 12,644,126 B2Massachusetts Institute of Technology
- Modification of small RNAs for therapeutic uses18 Nov 2025US 12,473,548 B2City of Hope
- Artificial nucleic acid molecules for improved protein expression14 Oct 2025US 12,442,005 B2CureVac AG
- Modification of RNA, producing an increased transcript stability and translation efficiency12 Aug 2025US 12,385,049 B2BioNTech SE
- Polynucleotide molecule comprising poly(a) and use thereof24 Sep 2026US 2026/0286369 A1Shenzhen Shenxin Biotechnology Co., Ltd.
- Mrna 3'utr sequence for inducing increased mrna translation17 Sep 2026US 2026/0275343 A1Korea Advanced Institute of Science and Technology
- Compositions comprising polyribonucleotides and uses thereof10 Sep 2026US 2026/0263639 A1Flagship Pioneering Innovations VI, LLC
- Circular rna vectors comprising modified nucleotides20 Aug 2026US 2026/0242805 A1University of Massachusetts
- Construct comprising utr sequence that improves intracellular stability and biosynthesis of mrna and use thereof19 Mar 2026US 2026/0078377 A1Theragen Bio Co., Ltd.
Most cited
By later US patents
- Method of identifying a stochastically-generated peptide, polypeptide, or protein having ligand binding property and compositions thereof519US 5,723,323 A1998
- Process for the production of stochastically-generated transcription or translation products347US 5,814,476 A1998
- Process for the production of expression vectors comprising at least one stochastic sequence of polynucleotides330US 5,824,514 A1998
- Process for the production of stochastically-generated peptides,polypeptides or proteins having a predetermined property317US 5,817,483 A1998
- Process for obtaining DNA, RNA, peptides, polypeptides, or proteins, by recombinant DNA technique289US 5,976,862 AIxsys, Inc. · 1999